-+ 0.00%
-+ 0.00%
-+ 0.00%

REZOLUTE ANNOUNCES ORAL PRESENTATION OF RESULTS FROM ITS PHASE 3 SUNRIZE STUDY OF ERSODETUG IN PATIENTS WITH CONGENITAL HYPERINSULINISM AT THE PEDIATRIC ENDOCRINE SOCIETY ANNUAL MEETING

Reuters·05/01/2026 16:15:00

Please log in to view news